Healthy children as subjects in pharmaceutical research

Recruitment of healthy children for drug research has emerged due in part to several new American laws and policies that have led to a surge in pharmaceutical research involving children-subjects. In this paper, I review the ethical and scientific issues and the arguments in favor and against this new practice.